31/08/2023  21:59:59 Diferencia -0.9100 Volumen Bid1:50:00 Ask1:50:00 Capitalización de mecado Dividendo A. P/E Ratio
39.7500USD -2.24% 31.37 millones
Volumen de negocios: 336.35 millones
39.2900Volumen de oferta: - 39.9000Tamaño/ Volumen/ Formato de Ask: - 2.08 mil millonesUSD - 50.96

Descripción de negocio

NuVasive is a global medical device company focused on transforming spine surgery by empowering surgeons with technology to approach procedures in the least disruptive way possible and restore the vitality of life for those that suffer from debilitating spinal conditions. Through its minimally invasive, procedurally-integrated solutions, the Company is expanding the boundaries of modern healthcare with technologies and surgeon training designed to provide reproducible and clinically-proven surgical outcomes that are redefining the success factors of spine surgery like never before. Addressing a variety of pathologies up and down the spine, from complex spinal deformity to degenerative spinal conditions, NuVasive's highly differentiated solutions include access instruments, implantable hardware and increasingly expert software systems like its game-changing iGA™ surgical planning and reconciliation technology that centers on achieving the global alignment of the spine. NuVasive believes its integrated approach and expertise can fundamentally evolve spine care by delivering improved patient experiences, and better economics for healthcare systems.
 

Consejo de gestión & Consejo de supervisión

CEO
J. Christopher Barry
Consejo de gestión
Matthew K. Harbaugh, Aviva McPherron, Brent Boucher, Dale Wolf, Kyle Malone, Lucas Vitale, Massimo Calafiore, Michael Farrington, Nathaniel Sisitsky, Sean Freeman
Consejo de supervisión
Daniel J. Wolterman, Amy Belt Raimundo, Donald J. Rosenberg, J. Christopher Barry, John A. DeFord, Leslie V. Norwalk, R. Scott Huennekens, Robert F. Friel, Siddhartha Kadia, Vickie L. Capps
 

Datos de la empresa

Nombre: NuVasive Inc.
Dirección: 7475 Lusk Boulevard,San Diego, California 92121, USA
Teléfono: +1-858-909-1800
Fax: +1-800-475-9134
E-mail: info@nuvasive.com
Internet: www.nuvasive.com/
Industria: Healthcare
Sector: Medical Products
Subsector: Advanced Medical Devices
Fin del año financiero: 31/12
Acciones de libre circulación: 60.20%
Fecha de OPI: -

Relación con inversores

Nombre: Juliet C. Cunningham
IR teléfono: +1-858-458-2240
IR-fax: -
IR e-mail: investorrelations@nuvasive.com

Accionistas mayoritarios

Freefloat
 
60.20%
Wellington Management Company LLP
 
13.00%
BlackRock, Inc.
 
12.20%
The Vanguard Group
 
9.40%
The Hartford Mutual Funds, Inc.
 
5.20%